Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen.
https://seekingalpha.com/news/4401460-ionis-stock-slips-novartis-delays-heart-drug-trial
Ionis Pharmaceuticals (IONS) stock slips as Novartis (NVS) delays Phase 3 trial data for its cardiac therapy pelacarsen.
https://seekingalpha.com/news/4401460-ionis-stock-slips-novartis-delays-heart-drug-trial
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.